CVS Health (NYSE:CVS), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025. The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a recent >10% stock rally. See more.

CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health care benefits and pharmacy and consumer wellness segments.

Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of $97.20 billion,

CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as its pace of medical cost increases slowed and revenue at its pharmacy business jumped, sending its shares up more than 12% in premarket trading.

Shares of CVS Health (CVS) surged in premarket trading Wednesday after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results. CVS reported adjusted earnings per share (EPS) of $1.